InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
1
T+90 胜率
0%
T+90 平均收益
-13.2%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Brennan David R, 董事. Director active across 5 companies, notably ALEXION PHARMACEUTICALS, INC.. Cumulatively, 12 reports have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €2.9m. History available since 20 May 2021. The latest transaction was disclosed on 9 September 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Brennan David R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
25,000 股@ US$124.00Common StockSEC:0001609305-26-000009:0
3,305 股Common StockSEC:0001609305-26-000004:0
6,000 股0Common StockSEC:0001609305-26-000002:0
60,000 股0Common StockSEC:0001609305-25-000004:0
5,058 股Common StockSEC:0001628280-25-026569:0
13,162 股Common StockSEC:0001628280-24-023560:0
13,192 股Common StockSEC:0001628280-23-018200:0
14,645 股Common StockSEC:0001140361-22-019182:0
10,000 股@ US$30.15100.0% 占其流量Common StockSEC:0001140361-21-036422:0
标准退出：2022年1月30日 (T+90)
20,873 股0Common Stock, par value $.0001 per shareSEC:0000899866-21-000070:0
1,962 股0Common Stock, par value $.0001 per shareSEC:0000899866-21-000040:0
7,558 股Common StockSEC:0001140361-21-017417:0
12 条申报中的 12 条
About Brennan David R
Brennan David R is Administrateur at INSMED Inc and ALEXION PHARMACEUTICALS, INC. The 11 filings recorded cover, for the sampled recent filings, the period from 2021-05-14 to 2026-05-15, with 260888 in purchases and 0 in sales, and the modal transaction nature is Attribution.
